# US 2021/0228892 A1 · Atrioventricular nodal stimulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228892 A1
- Document ID: US20210228892A1
- Status: Published application
- Kind: A1
- Application number: 17/157,433
- Filed: 2021-01-25
- Published: 2021-07-29
- Earliest claimed: 2020-01-27
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Lilian Kornet; Richard Cornelussen; Berthold Stegemann
- Web page: https://patentgrep.com/patent/US20210228892A1

## CPC

- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 1/37512: {Pacemakers}
- A61B 5/294: for nerve conduction study [NCS]
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/388: Nerve conduction study, e.g. detecting action potential of peripheral nerves
- A61B 5/4035: {Evaluating the autonomic nervous system}
- A61B 5/4052: {efferent nerves, i.e. nerves that relay impulses from the central nervous system}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61N 1/362: Heart stimulators (heart defibrillators A61N1/39)
- A61N 1/3702: {Physiological parameters (A61N1/365 takes precedence; evoked response A61N1/371)}
- A61N 1/3756: {Casings with electrodes thereon, e.g. leadless stimulators}
- A61N 1/3621: {for treating or preventing abnormally high heart rate}
- A61N 1/36507: {controlled by gradient or slope of the heart potential}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Devices and methods are described herein for treating cardiac conditions using electrical stimulation delivered to and sensing nerve activity from one or both of the AV node and nerve tissue innervating the AV node using one or more neural electrodes positioned in a location within the triangle of Koch of the right atrium.

## Claims

### Claim 1

An implantable medical device comprising:
a plurality of electrodes comprising at least one neural electrode implantable in the triangle of Koch region of the right atrium to deliver therapy to or sense nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart;
a therapy delivery circuit operably coupled to the plurality of electrodes to deliver therapy to the patient's heart;
a sensing circuit operably coupled to the plurality of electrodes to sense electrical activity of the patient's heart; and
a computing apparatus comprising processing circuitry operably coupled to the therapy delivery circuit and the sensing circuit, the computing apparatus configured to deliver electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode.

### Claim 2 (depends on 1)

The device of claim 1, wherein delivering electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode comprises delivering electrical stimulation to a region that is between 65 degrees and 125 degrees relative to a vertical axis passing though the coronary sinus ostium when viewed 30 degrees right anterior oblique using the at least one neural electrode.

### Claim 3 (depends on 1)

The device of claim 1, wherein delivering electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode comprises delivering electrical stimulation to a region that is between 8 millimeters and 16 millimeters from the coronary sinus ostium.

### Claim 4 (depends on 1)

The device of claim 1, further comprising a housing extending from a proximal end region to a distal end region, wherein the at least one neural electrode is leadlessly coupled to the distal end region of the housing, wherein the therapy delivery circuit, the sensing circuit, and the computing apparatus are enclosed within the housing.

### Claim 5 (depends on 1)

The device of claim 1, wherein the electrical stimulation is less than or equal to 8 volts, has a pulse width less than or equal to 2.5 milliseconds, has as frequency less than or equal to 60 hertz, and comprises less than or equal to 8 pulses.

### Claim 6 (depends on 1)

The device of claim 1, wherein the computing apparatus further configured to sense nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode.

### Claim 7 (depends on 6)

The device of claim 6, wherein the computing apparatus further configured to:
monitor parasympathetic activity of the nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode; and
initiate the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to the monitored parasympathetic activity.

### Claim 8 (depends on 6)

The device of claim 6, wherein the computing apparatus further configured to:
monitor efferent activity of the nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode; and
initiate the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to the monitored efferent activity.

### Claim 9 (depends on 1)

The device of claim 1 wherein the computing apparatus is further configured to initiate the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to detection of a supraventricular tachycardia.

### Claim 10 (depends on 1)

The device of claim 1, wherein the computing apparatus is further configured to initiate the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to detection of a cardiac inflammatory state or autonomic disbalance.

### Claim 11 (depends on 10)

The device of claim 10, wherein the computing apparatus is further configured:
monitor electrical activity of the patient's heart using the plurality of electrodes; and
detect one or both of a cardiac inflammatory state and an autonomic disbalance using the monitored electrical activity.

### Claim 12 (depends on 1)

The device of claim 1, wherein the computing apparatus is further configured to:
monitor cardiac depolarization electrical activity of the patient's heart using the at least one neural electrode; and
deliver electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode during the refractory periods based on the monitored cardiac depolarization electrical activity.

### Claim 13 (depends on 1)

The device of claim 1, wherein the computing apparatus is further configured to initiate the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode to reduce the patient's ventricular rate.

### Claim 14 (depends on 1)

The device of claim 1, wherein the computing apparatus is further configured to cease any delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to a monitored heart rate.

### Claim 15 (depends on 1)

The device of claim 1, wherein the plurality of electrodes further comprises an atrial electrode implantable from the triangle of Koch region of the right atrium to deliver cardiac therapy to or sense electrical activity in the myocardium of the patient's atrium,
wherein the computing apparatus is further configured to deliver cardiac pacing therapy to the patient's heart using the atrial electrode.

### Claim 16 (depends on 1)

The device of claim 1, wherein the at least one neural electrode is configured to deliver cardiac therapy to or sense electrical activity in the myocardium of the patient's atrium,
wherein the computing apparatus is further configured to deliver cardiac pacing therapy to the patient's heart using the at least one neural electrode.

### Claim 17 (depends on 1)

The device of claim 1, wherein the plurality of electrodes further comprises a ventricular electrode implantable from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body to deliver cardiac therapy to or sense electrical activity in the basal region, septal region, or basal-septal region of the left ventricular myocardium of the patient's heart,
wherein the computing apparatus is further configured to deliver cardiac pacing therapy to the patient's heart using the ventricular electrode.

### Claim 18 (depends on 17)

The device of claim 17, wherein the cardiac pacing therapy comprises anti-tachycardia pacing.

### Claim 19

A method comprising
providing a plurality of electrodes comprising at least one neural electrode implantable in the triangle of Koch region of the right atrium to deliver therapy to or sense nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart; and
delivering electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode.

### Claim 20 (depends on 19)

The method of claim 19, wherein delivering electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode comprises delivering electrical stimulation to a region that is between 65 degrees and 125 degrees relative to a vertical axis passing though the coronary sinus ostium when viewed 30 degrees right anterior oblique using the at least one neural electrode.

### Claim 21 (depends on 19)

The method of claim 19, wherein delivering electrical stimulation to one or both of the AV node or nerves innervating the AV node using the at least one neural electrode comprises delivering electrical stimulation to a region that is between 8 millimeters and 16 millimeters from the coronary sinus ostium.

### Claim 22 (depends on 19)

The method of claim 19, wherein the at least one neural electrode is leadlessly coupled to a distal end region of a housing enclosing a therapy delivery circuit, a sensing circuit, and a computing apparatus.

### Claim 23 (depends on 19)

The method of claim 19, wherein the electrical stimulation is less than or equal to 8 volts, has a pulse width less than or equal to 2.5 milliseconds, has as frequency less than or equal to 60 hertz, and comprises less than or equal to 8 pulses.

### Claim 24 (depends on 19)

The method of claim 19, wherein the method further comprises sensing nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode.

### Claim 25 (depends on 25)

The method of claim 25, wherein the method further comprises:
monitoring parasympathetic activity of the nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode; and
initiating the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to the monitored parasympathetic activity.

### Claim 26 (depends on 25)

The method of claim 25, wherein the method further comprises:
monitoring efferent activity of the nerve activity of one or both of the AV node or nerves innervating the AV node of the patient's heart using the at least one neural electrode; and
initiating the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to the monitored efferent activity.

### Claim 27 (depends on 19)

The method of claim 19, wherein the method further comprises initiating the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to detection of a supraventricular tachycardia.

### Claim 28 (depends on 19)

The method of claim 19, wherein the method further comprises initiating the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to detection of a cardiac inflammatory state or autonomic disbalance.

### Claim 29 (depends on 28)

The method of claim 28, wherein the method further comprises:
monitoring electrical activity of the patient's heart using the plurality of electrodes; and
detecting one or both of a cardiac inflammatory state and an autonomic disbalance using the monitored electrical activity.

### Claim 30 (depends on 19)

The method of claim 19, wherein the method further comprises:
monitoring cardiac depolarization electrical activity of the patient's heart using the at least one neural electrode; and
delivering electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode during the refractory periods based on the monitored cardiac depolarization electrical activity.

### Claim 31 (depends on 19)

The method of claim 19, wherein the method further comprises initiating the delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode to reduce the patient's ventricular rate.

### Claim 32 (depends on 19)

The method of claim 19, wherein the method further comprises ceasing any delivery of electrical stimulation to the one or both of the AV node or nerves innervating the AV node using the at least one neural electrode in response to a monitored heart rate.

### Claim 33 (depends on 19)

The method of claim 19, wherein the plurality of electrodes further comprises an atrial electrode implantable from the triangle of Koch region of the right atrium to deliver cardiac therapy to or sense electrical activity in the myocardium of the patient's atrium,
wherein the method further comprises delivering cardiac pacing therapy to the patient's heart using the atrial electrode.

### Claim 34 (depends on 19)

The method of claim 19, wherein the at least one neural electrode is configured to deliver cardiac therapy to or sense electrical activity in the myocardium of the patient's atrium,
wherein the method further comprises delivering cardiac pacing therapy to the patient's heart using the at least one neural electrode.

### Claim 35 (depends on 19)

The method of claim 19, wherein the plurality of electrodes further comprises a ventricular electrode implantable from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body to deliver cardiac therapy to or sense electrical activity in the basal region, septal region, or basal-septal region of the left ventricular myocardium of the patient's heart,
wherein the method further comprises initiating delivering cardiac pacing therapy to the patient's heart using the ventricular electrode.

### Claim 36 (depends on 35)

The method of claim 35, wherein the cardiac pacing therapy comprises anti-tachycardia pacing.
